STOCKHOLM, Sept. 3, 2020 /PRNewswire/ -- "We are proud to
bring our SyMRI software to the Japanese market" says Ulrik
Harrysson, CEO, SyntheticMR. "We have an established customer base
in Japan currently using the
product for research. Now we are excited to be able to offer SyMRI
for clinical use on the Japanese market. We know there are many
healthcare providers that are looking forward to utilize our
technology to speed up their current workflow and add additional
information to aid in diagnosis."
SyMRI provides multiple contrast weighted images and
quantitative information about the patient in a single 5-6-minute
scan, enabling users to speed up their imaging workflow and add
objective decision support to their practice.
CONTACT:
For additional information, please contact Ulrik Harrysson,
CEO, SyntheticMR AB, +46 70 529 29
87 ulrik.harrysson@syntheticmr.com.
This information was brought to you by Cision
http://news.cision.com
https://news.cision.com/syntheticmr-ab/r/syntheticmr-s-software-solution-symri-receives-regulatory-approval-in-japan,c3188143
The following files are available for download:
|
https://mb.cision.com/Main/11663/3188143/1301896.pdf
|
Release
|
View original
content:http://www.prnewswire.com/news-releases/syntheticmrs-software-solution-symri-receives-regulatory-approval-in-japan-301123724.html
SOURCE SyntheticMR AB